Evidence map›Paper›PMID 37053183›Full record

ArticlePloS one2023

Comparison of survival times of advanced cancer patients with palliative care at home and in hospital.

Jun Hamano, Ayano Takeuchi, Masanori Mori, Yasuhiro Saitou, Takahide Yamaguchi, Nobuyuki Miyata, Masakatsu Shimizu, Ryo Yamamoto, Yousuke Kimura, Yoshiyuki Kamiyama and 11 more

Open access · goldAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Characteristics of adolescent and young adult patients with cancer receiving home-based palliative care: A retrospective study at a single center.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 1 country.

Jun HamanoFaculty of Medicine, Department of Palliative and Supportive Care, University of Tsukuba, Tsukuba, Japan.ORCID 0000-0003-0304-9881
Ayano TakeuchiDepartment of Preventive Medicine and Public Health, School of Medicine, Keio University, Tokyo, Japan.
Masanori MoriDivision of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
Yasuhiro SaitouGP Clinic Jiyugaoka, Tokyo, Japan.
Takahide YamaguchiOhisama Medical Corporation, Ohisama Clinic, Hyogo, Japan.
Nobuyuki MiyataMiyata Clinic, Chikusei, Ibaraki, Japan.
Masakatsu ShimizuShimizu Medical Clinic, Akashi, Hyogo, Japan.
Ryo YamamotoSaku Central Hospital Advanced Care Center, Saku-shi, Nagano, Japan.
Yousuke KimuraYamato Clinic, Sakuragawa, Ibaraki, Japan.
Yoshiyuki KamiyamaOkinawa Chubu Hospital, Uruma, Okinawa, Japan.
Yasuyuki AraiIki-iki Clinic, Yuki, Ibaraki, Japan.
Hiroshi MatsuoMarguerite Clinic, Nagoya, Aichi, Japan.
Hideki ShishidoShishido Internal Medicine Clinic, Sakura, Chiba, Japan.
Kazushi NakanoNakano Zaitakuiryou Clinic, Ishiki, Kagosima, Japan.
Tomohiro NishiKawasaki Municipal Ida Hospital, Kawasaki, Kanagawa, Japan.
Hiroka NagaokaFaculty of Medicine, Department of Palliative and Supportive Care, University of Tsukuba, Tsukuba, Japan.
Naosuke YokomichiDivision of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
Isseki MaedaDivision of Palliative and Supportive Care, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
Takashi YamaguchiDepartment of Medicine, Division of Palliative Care, Konan Medical Center, Kobe, Japan.
Tatsuya MoritaDivision of Palliative and Supportive Care, Palliative Care Team, and Seirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu, Shizuoka, Japan.
Takuya ShinjoShinjo-clinic, Kobe, Hyogo, Japan.
Seirei Mikatabara General Hospital · JPUniversity of Tsukuba · JPHoshigaoka Medical Center · JPKawasaki Municipal Hospital · JPKeio University · JPMiyata Eye Hospital · JPNitobe Memorial Nakano General Hospital · JPOkinawa Prefectural Chubu Hospital · JPSaku Central Hospital · JPShimizu (Japan) · JPShinko Hospital · JPYamato University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesOne primary concern about receiving care at home is that survival might be shortened because the quality and quantity of treatment provided at home will be inferior to that given in the hospital. Although our previous study demonstrated a longer survival of those with home-based palliative care (PC), it lacked adjustment for some potential confounders including symptoms and treatments during the stay. We aimed to compare the survival times among advanced cancer patients receiving home-based and hospital-based PC with adjusting for symptoms and treatments.

methodWe compared survival time of participants who enrolled two multicenter, prospective cohort studies of advanced cancer patients at 45-home-based PC services between July 2017 and December 2017, and at 23-hospital-based PC services between January 2017 and December 2017. We analyzed with stratification by the estimated survival of Days, Weeks, and Months, which were defined by modified Prognosis in Palliative care Study predictor models-A. We conducted a Cox regression analysis with adjusting for potential confounders including symptoms and treatments during the stay.

resultsA total of 2,998 patients were enrolled in both studies and 2,878 patients were analyzed; 988 patients receiving home-based PC and 1,890 receiving hospital-based PC. The survival time of patients receiving home-based PC was significantly longer than that of patients receiving hospital-based PC for the Days Prognosis (estimated median survival time: 10 days [95% CI 8.1-11.8] vs. 9 days [95% CI 8.3-10.4], p = 0.157), the Weeks prognosis (32 days [95% CI 28.9-35.4] vs. 22 days [95% CI 20.3-22.9], p < 0.001), and the Months Prognosis, (65 days [95% CI 58.2-73.2] vs. 32 days [95% CI 28.9-35.4], p < 0.001).

conclusionIn this cohort of advanced cancer patients with a Weeks or Months prognosis, those receiving home-based PC survived longer than those receiving hospital-based PC after adjusting for symptoms and treatments.

Indexed as

NeoplasmsPalliative CareHospitalsHumansPrognosisProspective StudiesRetrospective Studies

Identifiers

PMID37053183
PMCPMC10101528
OpenAlexW4365442887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.